![Pharmaceutics | Free Full-Text | The Segregated Intestinal Flow Model (SFM) for Drug Absorption and Drug Metabolism: Implications on Intestinal and Liver Metabolism and Drug–Drug Interactions | HTML Pharmaceutics | Free Full-Text | The Segregated Intestinal Flow Model (SFM) for Drug Absorption and Drug Metabolism: Implications on Intestinal and Liver Metabolism and Drug–Drug Interactions | HTML](https://www.mdpi.com/pharmaceutics/pharmaceutics-12-00312/article_deploy/html/images/pharmaceutics-12-00312-g004.png)
Pharmaceutics | Free Full-Text | The Segregated Intestinal Flow Model (SFM) for Drug Absorption and Drug Metabolism: Implications on Intestinal and Liver Metabolism and Drug–Drug Interactions | HTML
![Bisphosphonate prodrugs: a new synthetic strategy to tetraacyloxymethyl esters of methylenebisphosphonates - ScienceDirect Bisphosphonate prodrugs: a new synthetic strategy to tetraacyloxymethyl esters of methylenebisphosphonates - ScienceDirect](https://ars.els-cdn.com/content/image/1-s2.0-S0040403999017992-gr1.gif)
Bisphosphonate prodrugs: a new synthetic strategy to tetraacyloxymethyl esters of methylenebisphosphonates - ScienceDirect
![Application of Intestinal Epithelial Cells Differentiated from Human Induced Pluripotent Stem Cells for Studies of Prodrug Hydrolysis and Drug Absorption in the Small Intestine | Drug Metabolism & Disposition Application of Intestinal Epithelial Cells Differentiated from Human Induced Pluripotent Stem Cells for Studies of Prodrug Hydrolysis and Drug Absorption in the Small Intestine | Drug Metabolism & Disposition](https://dmd.aspetjournals.org/sites/default/files/highwire/dmd/46/11.cover-source.jpg)
Application of Intestinal Epithelial Cells Differentiated from Human Induced Pluripotent Stem Cells for Studies of Prodrug Hydrolysis and Drug Absorption in the Small Intestine | Drug Metabolism & Disposition
Analytical Profiles of Drug Substances Volume 18 1989 | Acid Dissociation Constant | Differential Scanning Calorimetry
![Pharmaceutics | Free Full-Text | The Segregated Intestinal Flow Model (SFM) for Drug Absorption and Drug Metabolism: Implications on Intestinal and Liver Metabolism and Drug–Drug Interactions | HTML Pharmaceutics | Free Full-Text | The Segregated Intestinal Flow Model (SFM) for Drug Absorption and Drug Metabolism: Implications on Intestinal and Liver Metabolism and Drug–Drug Interactions | HTML](https://www.mdpi.com/pharmaceutics/pharmaceutics-12-00312/article_deploy/html/images/pharmaceutics-12-00312-g003.png)
Pharmaceutics | Free Full-Text | The Segregated Intestinal Flow Model (SFM) for Drug Absorption and Drug Metabolism: Implications on Intestinal and Liver Metabolism and Drug–Drug Interactions | HTML
![Pharmaceutics | Free Full-Text | The Segregated Intestinal Flow Model (SFM) for Drug Absorption and Drug Metabolism: Implications on Intestinal and Liver Metabolism and Drug–Drug Interactions | HTML Pharmaceutics | Free Full-Text | The Segregated Intestinal Flow Model (SFM) for Drug Absorption and Drug Metabolism: Implications on Intestinal and Liver Metabolism and Drug–Drug Interactions | HTML](https://www.mdpi.com/pharmaceutics/pharmaceutics-12-00312/article_deploy/html/images/pharmaceutics-12-00312-g006.png)
Pharmaceutics | Free Full-Text | The Segregated Intestinal Flow Model (SFM) for Drug Absorption and Drug Metabolism: Implications on Intestinal and Liver Metabolism and Drug–Drug Interactions | HTML
![Pharmaceutics | Free Full-Text | The Segregated Intestinal Flow Model (SFM) for Drug Absorption and Drug Metabolism: Implications on Intestinal and Liver Metabolism and Drug–Drug Interactions | HTML Pharmaceutics | Free Full-Text | The Segregated Intestinal Flow Model (SFM) for Drug Absorption and Drug Metabolism: Implications on Intestinal and Liver Metabolism and Drug–Drug Interactions | HTML](https://www.mdpi.com/pharmaceutics/pharmaceutics-12-00312/article_deploy/html/images/pharmaceutics-12-00312-g002.png)
Pharmaceutics | Free Full-Text | The Segregated Intestinal Flow Model (SFM) for Drug Absorption and Drug Metabolism: Implications on Intestinal and Liver Metabolism and Drug–Drug Interactions | HTML
Probody Therapeutics: An Emerging Class of Therapies Designed to Enhance On-Target Effects with Reduced Off-Tumor Toxicity for U
![Pharmaceutics | Free Full-Text | The Segregated Intestinal Flow Model (SFM) for Drug Absorption and Drug Metabolism: Implications on Intestinal and Liver Metabolism and Drug–Drug Interactions | HTML Pharmaceutics | Free Full-Text | The Segregated Intestinal Flow Model (SFM) for Drug Absorption and Drug Metabolism: Implications on Intestinal and Liver Metabolism and Drug–Drug Interactions | HTML](https://www.mdpi.com/pharmaceutics/pharmaceutics-12-00312/article_deploy/html/images/pharmaceutics-12-00312-g007-550.jpg)